Rising Thyroid Cancer and the PFAS Question
Thyroid cancer is one of the fastest-growing cancer diagnoses in developed nations—incidence has more than tripled in the United States over the past four decades. While improved diagnostic detection (particularly thyroid ultrasound) explains part of this increase, evidence of true incidence growth beyond detection effects suggests environmental contributors. PFAS compounds—with their documented thyroid hormone-disrupting properties—are among the environmental chemicals under investigation as potential thyroid carcinogenesis promoters, a hypothesis supported by mechanistic plausibility even as epidemiological evidence accumulates.
Mechanisms Linking PFAS to Thyroid Carcinogenesis
The thyroid gland is a site of PFAS accumulation: iodine transport proteins that concentrate iodine in thyroid follicles also transport certain PFAS compounds, potentially delivering PFAS directly to thyroid epithelial cells where carcinogenic transformation occurs. Within thyroid cells, PFAS may act through several carcinogenic mechanisms: activation of the MAPK (mitogen-activated protein kinase) and PI3K/Akt signaling pathways that promote cell proliferation and survival; induction of reactive oxygen species that damage DNA; alteration of thyroid transcription factor expression governing thyroid cell differentiation; and epigenetic modifications that silence tumor suppressor genes or activate oncogenes in thyroid tissue.
TSH (thyroid stimulating hormone) elevation—documented in populations with higher PFAS exposures—is itself a thyroid carcinogenesis risk factor. TSH stimulates thyroid cell proliferation through the TSH receptor; chronically elevated TSH creates the proliferative cellular environment in which cancer-promoting mutations accumulate and expand. If PFAS-induced TSH elevation is a mechanistic intermediary in thyroid carcinogenesis, it represents an indirectly mediated but nonetheless causal pathway between PFAS exposure and thyroid cancer risk.
Epidemiological Studies and Their Limitations
Epidemiological studies specifically examining PFAS and thyroid cancer are limited in number due to the rarity of thyroid cancer in any individual cohort and the long latency between PFAS exposure and cancer diagnosis. The C8 Health Project found a non-significant positive association between PFOA exposure and thyroid disease broadly defined, but thyroid cancer specifically was too rare in the cohort to analyze independently. An occupational cohort study of 3M workers—one of the most PFAS-exposed occupational groups—found elevated thyroid cancer rates compared to general population rates, though confounding by other occupational exposures limits causal inference.
Geographic correlation studies—comparing thyroid cancer rates in areas with high PFAS environmental concentrations to rates in lower-exposure areas—have produced mixed findings. Some studies find positive geographic correlations; others do not. The inherent limitations of ecological study designs prevent causal conclusions. The most informative prospective studies will require large cohorts with pre-cancer blood PFAS measurements, thorough cancer ascertainment over 20+ years of follow-up, and adjustment for diagnostic intensity differences—a research infrastructure investment that several ongoing cohort studies are positioned to deliver in the coming decade.
Regulatory Implications
Thyroid cancer as a regulatory endpoint for PFAS risk assessment raises complex issues. As a cancer endpoint with long latency and uncertain dose-response characteristics at environmental concentrations, thyroid cancer does not fit neatly into the current EPA quantitative risk assessment framework applied to more data-rich PFAS cancer endpoints. However, IARC’s classification of PFOA as a possible carcinogen (Group 2B, under review for upgrade) encompasses multiple cancer sites including thyroid, and the weight of evidence supporting PFAS as thyroid disruptors supports precautionary drinking water standards protective of thyroid cancer endpoints as well as the more established thyroid function effects.